Enzyme-Triggered Intestine-Specific Targeting Adhesive Platform for Universal Oral Drug Delivery
Exclusively Licensed
Invention type: Technology
/
Case number: #23242JQ
Provided herein are solid oral dosage forms, methods, and kits useful, e.g, for the extension of the residence time of active pharmaceutical agents in vivo by the synthesis of a polymer in situ in a subject. In particular, the solid oral dosage forms, methods, and kits disclosed herein are particularly useful for drugs that require more than once daily administration (e.g, drugs that have short half-lives).
Researchers
Robert Langer
/
Ying Li
/
Giovanni Traverso
Departments: Office of the Institute Professors, Department of Mechanical Engineering
Technology Areas: Chemicals & Materials: Polymers
Impact Areas: Healthy Living, Advanced Materials
-
solid oral dosage forms, kits, and methods of using the same
Patent Cooperation Treaty | Published application
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.